Paediatric Healthcare Market by Treatment (Immunotherapy, Medications, Surgeries), Indication (Asthma & Allergies, Cardiac Disorders, Genetic Disorders), End-User - Global Forecast 2024-2030
The Paediatric Healthcare Market size was estimated at USD 107.01 billion in 2023 and expected to reach USD 114.55 billion in 2024, at a CAGR 7.53% to reach USD 177.94 billion by 2030.
Pediatric healthcare is a branch of medicine pertaining to the provision of medical care to infants, children, and adolescents. The age range typically considered for pediatric care is from birth up to 18 years. This field of healthcare encompasses a wide range of services, including prophylactic health care for healthy children and medical care for those who are acutely and chronically ill. Growing awareness among child parents of the need for adequate treatment, supported by rising government support and initiatives to promote pediatric health, has significantly contributed to the growth of the market. In addition, increasing investments in research & development for pediatric-specific medical devices and pharmaceuticals have a positive impact on market expansion. Despite the growth, the market faces several challenges, including high costs associated with pediatric care and specialty drugs, a shortfall in pediatric healthcare professionals, and uneven access to healthcare services across different regions. Regulatory hurdles for the approval of pediatric pharmaceuticals and devices also constitute significant limitations, as does the complexity of managing diverse health issues in a pediatric population. Technological advancements in neonatal and pediatric care equipment create lucrative opportunities for market growth. Additionally, the market sees potential in expanding access through telehealth services tailored for children and in integrating AI and machine learning to improve pediatric diagnostic and treatment protocols.
Regional InsightsIn the American region, pediatric healthcare is characterized by a combination of private and public funding, with an emphasis on innovation in treatment and drug development. Consumer needs are heavily influenced by the availability of advanced healthcare infrastructure and a strong focus on preventive care. Customer purchasing behavior leans towards providers that offer comprehensive services and holistic care. Investments in pediatric research are significant, with initiatives often funded through public-private partnerships. The European Union presents a diverse healthcare landscape with varying levels of access and quality. The common trend towards equitable healthcare systems is built on universal coverage. Consumer needs in pediatric healthcare focus on integrative services that address both the physiological and psychological aspects of child development. Emerging research within EU countries often explores the efficacy of pediatric treatments and health system improvements. The European Commission supports several research initiatives and collaborations aimed at enhancing pediatric healthcare. The APAC market is rapidly growing, with government policies favoring expanded coverage and improved healthcare access for children. Countries including China, India, and Japan are seeing significant research investment, particularly in the development of pediatric drugs and vaccines.
Market InsightsMarket DynamicsThe market dynamics represent an ever-changing landscape of the Paediatric Healthcare Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market DriversIncreasing number of deaths attributed to viral infections and malnutrition
Rising government support and initiatives to promote pediatric health
Growing awareness among child parents for adequate treatment
Market RestraintsEthical concerns and small size of the study population
Market OpportunitiesGrowing research and development in technological advancements
Surge in medical expenditure in emerging economies
Market ChallengesLack of pediatricians across the globe
Market Segmentation AnalysisTreatment: Expanding usage of pediatric healthcare for immunotherapy for a myriad of health conditions
Indication: Growing need for effective, age-appropriate medications in pediatric healthcare to manage asthma & allergies
End-User: Growing usage of pediatric healthcare across hospitals & clinics that offer a wide range of services
Market Disruption AnalysisPorter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning MatrixThe FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Paediatric Healthcare Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share AnalysisThe market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Paediatric Healthcare Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent DevelopmentsCortica Closes USD 75 Million in New Funding Round and Acquires Springtide Child Development
Cortica, a provider of full-spectrum autism services led by physicians, has successfully raised USD 75 million in a funding round spearheaded by Deerfield Management and Optum Ventures. Furthermore, Cortica has broadened its influence in pediatric healthcare through the acquisition of the Melmed Center, a developmental pediatrics clinic and research institution in Arizona. Cortica's expansion now encompasses 23 integrated autism centers nationwide, indicating a significant advancement in its mission to deliver comprehensive care to children with developmental differences.
Pediatric Behavioral Health Provider Bend Health Moves Out of Stealth Mode with USD 32M in Funding
Based in Madison, Wisconsin, Bend Health, a telebehavioral health enterprise specializing in pediatric services, has successfully closed a USD 32 million funding round. This significant financial milestone propels the startup from its beginnings towards national expansion, allowing for enhancements to operational processes and the recruitment of additional clinical experts.
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases
Ipsen Pharma has announced a definitive agreement to acquire Albireo, a company specializing in the development of bile-acid modulators designed to treat pediatric and adult cholestatic liver diseases. This strategic move is set to enhance Ipsen's rare disease portfolio, particularly with Albireo's flagship product, Bylvay (odevixibat), which is an FDA and EMA-approved treatment for pruritus associated with progressive familial intrahepatic cholestasis (PFIC) in young patients.
Strategy Analysis & RecommendationThe strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Paediatric Healthcare Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company ProfilesThe report delves into recent significant developments in the Paediatric Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Aveanna Healthcare, LLC., Becton, Dickinson and Company, bioMérieux SA, Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Enviva Inc., Gilead Sciences, Inc., Glaxosmithkline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Interim HealthCare Inc., Janssen Global Services LLC, Johnson & Johnson Services, Inc., Medexus Pharmaceuticals, Inc., Medtronic PLC, Merck KGaA, Novartis AG, Olympus Corporation, ORPHELIA Pharma, Pfizer Inc., Proveca Ltd., Royal Philips, Sanofi S.A, Siemens AG, Strykar Corporation, The Procter & Gamble Company, Thermo Fisher Scientific, Inc., and Viatris Inc..
Market Segmentation & CoverageThis research report categorizes the Paediatric Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:
Treatment
Immunotherapy
Medications
Surgeries
Indication
Asthma & Allergies
Cardiac Disorders
Genetic Disorders
Metabolic Disorders
End-User
Ambulatory Care Centers
Homecare Settings
Hospitals & Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year